More than three thousand walkers and runners are expected to lace up their sneakers and raise money for cancer research on Saturday, October 1st at the sixth annual Winship Win the Fight 5K.
The fourth Winship Cancer Institute Gala is being called the most successful fundraising event in Emory University's history, raising more than $1.3 million dollars. The proceeds will benefit cancer research at Winship.
A new clinical study by Winship Cancer Institute of Emory University seeks to increase the number of women at hereditary risk for breast and ovarian cancer who are seen for genetic counseling services.
Emory Winship cancer biologist Xingming Deng, MD, PhD and his lab have identified two novel agents which could reverse the resistance of cancer cells to treatment.
Emory Johns Creek Hospital is now utilizing the new Affirm 3D biopsy system to better target and sample breast lesions that may not have been detected on traditional 2D mammography systems.
A Winship Cancer Institute physician assistant and a longtime volunteer are the first recipients of the Robert L. "Bobby" Rearden Spirit of Winship Award.
The Emory, Harvard, and University of Washington Prostate Cancer Biomarker Center has received a $4.2 million grant from the National Cancer Institute's Early Detection Research Network to develop multiplex tests for detecting prostate cancer.
Scientists have devised a triple-stage "cluster bomb" system for delivering the chemotherapy drug cisplatin, via tiny nanoparticles designed to break up when they reach a tumor.
A new study using cryoablation to decrease pain for patients who have cancer metastases in the bone is now underway throughout Emory Healthcare.
Winship Cancer Institute at Emory Johns Creek Hospital and Dr. Seth Rosen will hold a free lecture to discuss colorectal cancer awareness.